Ottawa, Canada

David F Stojdl

USPTO Granted Patents = 13 

 

 

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 52(Granted Patents)


Location History:

  • Ontario, CA (2012)
  • Ottawa, CA (2007 - 2023)

Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: David F Stojdl: Innovator in Oncolytic Virus Research

Introduction

David F Stojdl is a prominent inventor based in Ottawa, Canada. He has made significant contributions to the field of cancer treatment, particularly through his research on oncolytic viruses. With a total of 13 patents to his name, Stojdl's work is paving the way for innovative therapies in oncology.

Latest Patents

One of Stojdl's latest patents focuses on compositions and methods for glioblastoma treatment. This patent discusses an oncolytic virus designed for the treatment of brain cancer, specifically glioblastoma. The oncolytic virus is characterized by reduced levels of neurotoxicity, making it a promising candidate for safer cancer therapies. The virus is described as an isolated viral particle capable of producing a cDNA polynucleotide that includes a specific sequence when in a host cell. Additionally, it may contain an RNA polynucleotide with another defined sequence. The genome of this oncolytic virus includes open reading frames that encode proteins with specific sequences, which are crucial for its therapeutic efficacy.

Career Highlights

Throughout his career, David F Stojdl has worked with notable organizations, including Turnstone Limited Partnership and the Children's Hospital of Eastern Ontario Research Institute. His research has significantly advanced the understanding and treatment of cancer, particularly through innovative viral therapies.

Collaborations

Stojdl has collaborated with esteemed colleagues such as John Cameron Bell and Brian D Lichty. These partnerships have fostered a collaborative environment that enhances research and development in the field of oncology.

Conclusion

David F Stojdl's contributions to cancer research through his innovative work on oncolytic viruses are noteworthy. His patents and collaborations reflect a commitment to advancing medical science and improving treatment options for patients with glioblastoma.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…